PharmaEssentia
Taipei · Founded 2003
About PharmaEssentia
PharmaEssentia Corporation is a biopharmaceutical company that develops treatments for myeloproliferative neoplasms, and hepatitis. They deliver biologics for diseases in the areas of hematology and oncology, with products approved in a diversifying pipeline. Their services include biologics, oncology, rare disease, orphan drugs, orphan disease, drug development, pharmaceuticals, and hematology.
Company Facts
- Founded: 2003
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $462.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2023)
- Ticker: tpe:6446
- Website: us.pharmaessentia.com
- Phone: +886-2-2655-7688
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pharmaessentia-846 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.